# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001023024-24-000039
Filing Date
2024-04-05
Accepted
2024-04-05 16:09:03
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | defa14a.htm | DEFA14A | 12006
2 |  | anipharmaceuticalsinc_vxnab.jpg | GRAPHIC | 837839
3 |  | anipharmaceuticalsinc_vxnac.jpg | GRAPHIC | 453345
| Complete submission text file | 0001023024-24-000039.txt |  | 1790448

Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31812 | Film No.: 24826546
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)